ReviewScience & practice perspectives2004
Practical considerations for the clinical use of buprenorphine.
Review in Science & practice perspectives, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 72 citations in OpenAlex.
- MySafeRx: a mobile technology platform integrating motivational coaching, adherence monitoring, and electronic pill dispensing for enhancing buprenorphine/naloxone adherence during opioid use disorder treatment: a pilot study.Addiction science & clinical practice · 2018Trial
- Pharmacodynamic and pharmacokinetic assessment of electronic cigarettes, combustible cigarettes, and nicotine gum: implications for abuse liability.Psychopharmacology · 2017Trial
- Pain volatility and prescription opioid addiction treatment outcomes in patients with chronic pain.Experimental and clinical psychopharmacology · 2015Trial
- Participant characteristics and buprenorphine dose.The American journal of drug and alcohol abuse · 2011Trial
- Induction of opioid-dependent individuals onto buprenorphine and buprenorphine/naloxone soluble-films.Clinical pharmacology and therapeutics · 2011Trial
- A randomized trial of transcutaneous electric acupoint stimulation as adjunctive treatment for opioid detoxification.Journal of substance abuse treatment · 2010Trial
- [Challenges in the treatment of opioid dependence].Der Nervenarzt · 2024Review
- Buprenorphine/naloxone versus methadone opioid rotation in patients with prescription opioid use disorder and chronic pain: study protocol for a randomized controlled trial.Addiction science & clinical practice · 2022Article
- Intraperitoneal injection of buprenorphine on anxiety-like behavior and alteration in expression ofVeterinary research forum : an international quarterly journal · 2022Article
- Outpatient Microdose Induction with Transdermal Buprenorphine: A Case Series.Healthcare (Basel, Switzerland) · 2022Article
- Sex specific effects of buprenorphine on behavior, astrocytic opioid receptor expression and neuroinflammation after pediatric traumatic brain injury in mice.Brain, behavior, & immunity - health · 2022Article
- Management of Psychiatric Disorders in Patients with Cardiovascular Diseases.Indian journal of psychiatry · 2022Article
- "You're Not Supposed to be on it Forever": Medications to Treat Opioid Use Disorder (MOUD) Related Stigma Among Drug Treatment Providers and People who Use Opioids.Substance abuse : research and treatment · 2022Article
- Microdose induction of buprenorphine-naloxone in a patient using high dose methadone: A case report.The mental health clinician · 2021Article
- A review of the existing literature on buprenorphine pharmacogenomics.The pharmacogenomics journal · 2021Review
- Successful Transition from High-Dose Methadone to Buprenorphine via Microdosing in the Outpatient Setting: A Case Report.The Canadian journal of hospital pharmacy · 2021Article
- New Approaches in Drug Dependence: Opioids.Current addiction reports · 2021Review
- Challenges in implementing opioid agonist therapy in Lebanon: a qualitative study from a user's perspective.Substance abuse treatment, prevention, and policy · 2018Article
- Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome.AJP reports · 2017Article
- Volatility and change in chronic pain severity predict outcomes of treatment for prescription opioid addiction.Addiction (Abingdon, England) · 2017Article
Corrections and comments
- Commented on by
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
Buprenorphine is a new and attractive medication option for many opioid-addicted adults and their physicians. Before initiating buprenorphine treatment, providers must be aware of such critical factors as how the medication works, its efficacy and safety profile, how it is used in opioid withdrawal as well as maintenance treatment, and how patients can best be selected, educated about buprenorphine, and monitored throughout treatment. This article reviews these important issues as well as requirements for physician and staff training and needs for additional research on this unique medication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.